Home > Press > Industrial Nanotech, Inc. Announces Revenue for Q3 2010: Approximately $1,036,047.00 US.
Abstract:
Industrial Nanotech, Inc. (Pink Sheets:INTK), an emerging global leader in nanoscience energy saving solutions, today announced that the sales revenue for the 3 month period ending September 30, 2010 was $1,036,047.00 US.
"The change in the economic conditions that we all experienced in 2009 forced us to rethink, revise and retool our strategy and supplement the reduced revenue from the homeowner Do-It-Yourself market with increased focus on the longer sales cycle major industrial corporations", states Stuart Burchill, CEO/CTO of Industrial Nanotech, Inc. "Fortunately, we had spent the previous five years diligently and methodically establishing proof of the value added proposition that our technology provides to industries around the world, including the fact that it pays for itself in typically 6-18 months by significantly reducing energy consumption and improving critical sustainability initiatives. Our patented Nansulate product line of award winning, energy saving protective specialty coatings containing a nanotechnology based material are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation."
Mr. Burchill continued, "Armed with an innovative, sustainable product line and solid data to back up its extraordinary performance and case studies of companies saving more in just the first year than the product cost them, plus the additional savings year after year, we just worked harder and smarter to get the message out to major global industrial companies and the results are testimonial to our strategy. Our technology simply offers value in cost savings, energy savings and carbon footprint reduction which companies are recognizing and implementing. We have reason to be optimistic about both the near term and long term likelihood of continued growth and success and we look forward to continuing to serve our customers well and enhance our shareholder value."
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
####
About Industrial Nanotech
Industrial Nanotech Inc. is a global nanoscience solutions and research leader and member of the U.S. Greenbuilding Council, the American Solar Energy Society, and an official ALLY organization with the U.S. Dept. of Energy "Save Energy Now" program. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.
For more information, please click here
Copyright © Industrial Nanotech
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||